World Alzheimer Report 2021: Innovations in diagnosis and diagnostics (Webinar)

This 90-minute webinar is centred around the World Alzheimer Report 2021 and features a diverse global panel of experts on diagnosis, diagnostics and innovation.

During this webinar, panelists discuss the incredibly important evolution in diagnostics for dementia, with conversations including: the current and future role of neuro imaging (scans/scanners); the role and perceptions around CSF (cerebrospinal fluid), the emergence of new biomarkers and the potential impact they could have on the diagnosis pathway; healthcare systems and the impact on people receiving and living with a diagnosis.

00:00:00 ADI CEO, Paola Barbarino, provides an overview of the webinar and introduces the panel
00:07:45 Professor José A. Morais, Director of the Division of Geriatric Medicine and Academic Lead for the Dementia Education Programme at McGill University, speaks on biomarkers
00:12:50 Sasha Boveat, Senior International Medical Affairs Manager, Roche; 'Diagnostic innovation through the perspective of an integrated diagnostic/treatment strategy'
00:22:23 Gill Farrar, Global Head of PET Neurology, GE Healthcare; 'PET technology and its role in the diagnosis of dementia'
00:30:40 Dr Emily Largent, Emanuel and Robert Hart Assistant Professor of Medical Ethics, University of Pennsylvania Perel School of Medicine; 'Anticipating Blood-Based Biomarkers for Alzheimer's Disease'
00:38:25 Professor Zoe Kourtzi, Professor of Cognitive Computational Neuroscience, Alan Turing Fellow; 'AI-guided solutions for early prediction of neurodegenerative disease disorders'
00:46:26 Kate Swaffer, CEO and Co-founder, Dementia Alliance International, speaks on the existing stigma around receiving a dementia diagnosis
00:54:25 Dr Linda Sommerlade, Head of Operations at GT Diagnostics, speaks about global diagnosis rates and how GT Diagnostics is responding
01:02:25 Q&A session with the audience and panelists

Follow us